Inactive Instrument

FoxWayne Enterprises Acquisition Corp.

FOXW

US35166L1098

FOXWAYNE ENTERPRISES ACQUISITION CORP. : Other Events (form 8-K)

December 09, 2022 at 03:32 am IST

Item 8.01 Other Events.

On December 8, 2022, Foxwayne Enterprises Acquisition Corp. (the "Company") determined to cancel its special meeting of stockholders that was originally scheduled for November 30, 2022 and postponed until December 13, 2022, and to withdraw from consideration by the stockholders of the Company the proposals set forth in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on November 3, 2022.

-2-

Latest news about FoxWayne Enterprises Acquisition Corp.

FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) dropped from NASDAQ Composite Index	27/23/27	CI
Clover Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from a group of shareholders in a reverse merger transaction.	12/23/12	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Clover Inc. entered into a definitive business combination agreement to acquire FoxWayne Enterprises Acquisition Corp. from a group of shareholders for approximately $160 million in a reverse merger transaction.	20/22/20	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt	31/22/31	CI
Aerami Therapeutics Holdings, Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others in a reverse merger transaction.	04/22/04	CI
Aerami Therapeutics to Go Public Via Merger with Blank-Check Firm FoxWayne Enterprises	07/21/07	MT
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05/21/05	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12/21/12	CI
Aerami Therapeutics Holdings, Inc. executed a non-binding letter of intent to acquire FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others for approximately $250 million in a reverse merger transaction.	11/21/11	CI
Certain Class B Common Stock of FoxWayne Enterprises Acquisition Corp. are subject to a Lock-Up Agreement Ending on 19-JUL-2021.	19/21/19	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	22/21/22	CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	30/21/30	CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt	29/21/29	CI
FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) added to NASDAQ Composite Index	26/21/26	CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $2.8 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	22/21/22	CI
FoxWayne Enterprises Acquisition Corp. has completed an IPO in the amount of $50 million.	19/21/19	CI
FoxWayne Enterprises Acquisition Corp. has filed an IPO in the amount of $50 million.	08/20/08	CI
FoxWayne Enterprises Acquisition Corp. announced that it expects to receive $2 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	08/20/08	CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $0.025 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC	15/20/15	CI

Chart FoxWayne Enterprises Acquisition Corp.

Duration

Period

Chart FoxWayne Enterprises Acquisition Corp.

More charts

Company Profile

FoxWayne Enterprises Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses for a target business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The Company has operations and has no revenues.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+198.00%	717.81Cr
CHURCHILL CAPITAL CORP VII	+2.19%	98Cr
APPLE ISPORTS GROUP, INC.	+41.91%	87Cr
PERELLA WEINBERG PARTNERS	+25.43%	81Cr
ARES ACQUISITION CORPORATION II	+1.77%	66Cr
E7 GROUP	+6.82%	64Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
ADMIRAL ACQUISITION LIMITED	+3.61%	50Cr
CAPITOL INVESTMENT CORP. VII	-.--%	50Cr

Shell Companies